Avidity Partners Management LP Eli Lilly & CO Transaction History

Avidity Partners Management LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $8.88 Million - $11.9 Million	-15,000 Reduced 17.65%	70,000 $54.5 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $5.25 Million - $6.19 Million	10,000 Added 13.33%	85,000 $49.5 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $25.2 Million - $34.8 Million	-58,000 Reduced 43.61%	75,000 $40.3 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $46.6 Million - $62.4 Million	133,000 New	133,000 $62.4 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $254 Million - $296 Million	-790,000 Reduced 78.45%	217,000 $79.4 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $118 Million - $134 Million	397,000 Added 65.08%	1,007,000 $326 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $170 Million - $200 Million	610,000 New	610,000 $198 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $80.9 Million - $101 Million	-344,800 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $3.33 Million - $4.13 Million	14,800 Added 4.48%	344,800 $95.2 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $52.2 Million - $64.2 Million	-235,500 Reduced 41.64%	330,000 $76.2 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $102 Million - $132 Million	565,500 New	565,500 $130 Million
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $133 Million - $172 Million	-810,500 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $106 Million - $140 Million	810,500 New	810,500 $137 Million

3,887

763M

6.34M

7.97M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.